Privacy Policy

General

EMD Serono respects the privacy of every individual who visits www.serostim.com (the "Web Site"). This Privacy Policy outlines the information EMD Serono will collect and how we will use that information.

Personally-Identifiable Information

There may be cases where EMD Serono will ask you for personally-identifiable information such as your name, mailing address, and email address. For example, we may request personally-identifiable information when you participate in a survey, contest, or other service that requires registration or subscription. EMD Serono will not collect any personally-identifiable information about you unless you provide it to us voluntarily.

When you view the website, we may store some information on your computer. This information will be in the form of a "cookie" or similar file and will help us to offer increased personalization and functionality. With most internet browsers, you can erase cookies from your computer hard drive, block all cookies, or receive a warning before a cookie is stored. Please refer to your browser instructions or help screen to learn more about these functions.

Except as stated in this Privacy Policy, or as otherwise stated at the time personally-identifiable information is gathered, we will not provide personally-identifiable information to third parties who are not under the direction and control of EMD Serono.

Children

The Web Site is not directed at individuals under thirteen years of age, and EMD Serono does not intend to collect any personally-identifiable information from such individuals, unless otherwise stated at the time such information is collected.

Information Collected Automatically

EMD Serono may also automatically collect non-personally-identifiable information about your use of the Web Site, such as the domain from which you access the Internet (for example, aol.com, if you are connecting from an America Online account), the date and time you access the Web Site, and the Internet address of the website from which you linked directly to our Web Site. This information will not be linked to personally-identifiable information. EMD Serono may use this information to analyze and enhance the Web Site, and may aggregate this information and share such aggregated information with business partners, sponsors and other third parties.

Links to Other Web Sites

The Web Site may allow links to various other web sites. EMD Serono assumes no responsibility for the information practices of sites you are able to access through the Web Site. These links to other sites do not imply affiliation or endorsement of a linked site.

Security

The importance of security for all personally-identifiable information associated with visitors to the Web Site is of utmost concern to us. Unfortunately, no data transmission over the Internet can be guaranteed to be secure. As a result, EMD Serono cannot ensure or warrant the security of any information you transmit to us, and you do so at your own risk. Once we receive your personally-identifiable information, we will take reasonable efforts to ensure its security on our systems.

Your Acceptance of These Terms

By using the Web Site, you signify your assent to the EMD Serono Privacy Policy. If you do not agree to this Policy, please do not use the Web Site. Your continued use of the Web Site following the posting of changes to these terms will mean you accept those changes. EMD Serono will, however, use personally-identifiable information only in accordance with the version of the Privacy Policy under which the information was collected.

Terms and Conditions of Use

Use of the Web Site is governed by the EMD Serono Legal Statement.

Important Risk Information and IndicationToggle Button

Important Risk Information and Indication

Before beginning treatment, patients should discuss with their clinician potential benefits and risks associated with Serostim® [somatropin (rDNA origin) for injection].

You should NOT take Serostim® if:

  • You are hospitalized with complications due to heart or abdominal surgery
  • You are hospitalized for serious injuries
  • You are hospitalized for respiratory failure
  • You currently have cancer. Any cancer treatment should be completed before starting Serostim®
  • You are allergic to growth hormone products or any materials associated with the product

You should tell your clinician if:

  • You are pregnant or breastfeeding
  • You are currently taking any medications for HIV
  • You have a history of diabetes

The most common adverse reactions associated with Serostim® are:

  • Muscle aches
  • Joint pain
  • Swelling (particularly of the hands or feet)

These side effects were generally mild-to-moderate in severity, and were often managed by lowering the dose.1

High blood glucose (sugar levels) may occur in HIV-infected individuals for many reasons and has also been reported in Serostim® clinical studies. If you have a history of high blood glucose or have other risk factors for glucose intolerance, you should be monitored closely while on Serostim®. New onset type 2 diabetes or worsening of current diabetes has been reported with Serostim®. Patients have experienced complications of diabetes, some of which were serious and continued after stopping treatment with Serostim®.

What is Serostim®?

Serostim® is human growth hormone and is the only FDA-approved medicine clinically proven to significantly increase lean body mass and body weight, and improve physical endurance. You must be on anti-retroviral therapy to be prescribed Serostim®.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

This information is not intended to replace discussions with your doctor. For additional information about Serositm® please consult the Prescribing Information and ask your doctor if Serostim® is right for you. You can also call the AXIS Center toll-free at 1-877-714-AXIS (2947). Serostim® is available by prescription only.

Please see Serostim® Prescribing Information available in English and Spanish

Reference:

  1. Moyle GJ, Daar ES, Gertner JM, et al. Growth hormone improves lean body mass, physical performance, and quality of life in subjects with HIV-associated weight loss or wasting on highly active antiretroviral therapy. J Acquir Immune Defic Syndr. 2004;35:367-375.

Indication

Serostim® is indicated for the treatment of HIV patients with wasting or cachexia to increase lean body mass and body weight, and improve physical endurance. Concomitant antiretroviral therapy is necessary.